Asking Price Contact for pricing
Area Size
NOI Net Operating Income N/A
NIY N/A

Documents

I accept the confidentiality agreement
Create an account on the Investor Center to save your search and investment preferences, save and share opportunities, access exclusive documents, and more. More questions? Visit our FAQ. Approval for Deal Room access requires review by our Broker Team. You will be notified by email once your access is granted. More questions? Visit our FAQ. You'll need to sign a Confidentiality Agreement (CA) to access exclusive documents in the Deal Room. Signing the CA means you agree not to divulge or release sensitive information related to this property. More questions? Visit our FAQ.
I accept the confidentiality agreement I accept the confidentiality agreement
Create an account on the Investor Center to save your search and investment preferences, save and share opportunities, access exclusive documents, and more. More questions? Visit our FAQ. You'll need to sign a Confidentiality Agreement (CA) to access exclusive documents in the Deal Room. Signing the CA means you agree not to divulge or release sensitive information related to this property. More questions? Visit our FAQ.

Attributes

Year Built 1975
Building Area Net
Land Area Net ()
Occupancy 100.0 %
Call for Offers 2022-05-03

Asset Description

Jones Lang LaSalle Americas, Inc. (“JLL”), as exclusive representative of the owner, is pleased to present for sale 466 Devon Park Drive in Wayne, Pennsylvania (the “Property”). The Property is a 100% leased lab facility at a mission critical location in the Route 202 Corridor with over 14 years of remaining lease term. Located in the highly desirable King of Prussia / Wayne submarket, the Property is strategically positioned along the Route 202 corridor and features superior local and regional access to the area’s busiest roadways including Route 422, Route 202, The Pennsylvania Turnpike (I-276), Interstate 76 and Interstate 476. 

Investment Highlights

IMPRESSIVE IN-PLACE CASH FLOW WITH 14 YEARS OF LEASE TERM

  • The Property is currently leased to Charles Rivers Laboratories (NYSE: CRL) through June 2036, which demonstrates a strong commitment to both the location and the facility. The impressive in-place cash flow includes contractual 3.0% annual rental increases providing an investor with consistent net operating income growth. The Property benefits from a Good Manufacturing Practice (GMP) designation from the FDA allowing the tenant to provide a commercialized product or conduct clinical trials. 

STRONG TENANT PROFILE

  • Founded in 1947, Charles Rivers Laboratories (NYSE: CRL) is an early stage contract research company providing drug discovery, non-clinical development and safety testing services to clients. CRL works with leading pharmaceutical, biotechnology, agrochemical, government and academic organizations around the world.

CORE ASSET WITH SIGNIFICANT CAPITAL INVESTMENT

  • Both the existing owner and Tenant have invested significant capital to upgrade and fit-out this core building to the highest standard. CRL has invested approximately $8 million in improvements to customize the facility in addition to the wide range of specialized equipment located at the Property. The existing owner has invested $3.4 million to upgrade the façade, replace the roof, install LED lighting, enhance the HVAC systems chillers, and created an amenity center including a fitness, cafe and conference facilities.

STRATEGICALLY POSITIONED WITHIN PHILADELPHIA’S LIFE SCIENCES HUB

  • Greater Philadelphia’s large concentration of leading academic institutions and pharmaceutical companies has created a central life sciences hub in the United States. 466 Devon Park Drive is situated along the Route 202 Corridor which is home to more than 37 percent of Philadelphia’s lab space. Considering the close proximity to New York’s financial markets and Washington DC’s regulatory center, more than 1,200 life science companies are based in the Philadelphia area ranging from the industry’s largest multinational companies to the sector’s fastest growing firms. More than 30 cell and gene therapy development companies and roughly 87 percent of all pharmaceutical and biotech companies in the U.S. have offices in Greater Philadelphia.

DIRECT ACCESS TO A DEEP AND SKILLED LABOR POOL OF WELL-EDUCATED PROFESSIONALS

  • Philadelphia has the largest concentration of healthcare in the country with over 120 hospitals, 200 pharmaceutical and biotechnology firms and 135 medical manufacturers throughout the region. In addition to the large number of medical schools, multiple universities in the region also offer advanced degrees in biological sciences providing a deep labor pool.
Last Updated Date: 04 Apr 2022

There was an error submitting your request. Please try again, or submit you inquiry here.

 

PRIVACY NOTICE

Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.

Generally the personal information we collect from you are for the purposes of dealing with your enquiry.

We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.

Last Updated Date: 04 Apr 2022

Do you have any questions?  Visit our FAQ page

JLL  financing

JLL can help you finance and manage your portfolio.
Email us today to see how we can help achieve your ambitions.